BK

Babar Kailay

Active Director Director DIN 10421301
DIN 10421301 First appointment Dec 2023 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About Babar Kailay

Data last updated:

Babar Kailay is a Director at Unimad Pharmaceuticals Pvt Ltd (since 2023). The company operates in Chemicals. Unimad Pharmaceuticals Pvt Ltd reported revenue of ₹20.5 Lakh (FY 2024).

DIN 10421301
Primary Designation Director
Industry Chemicals
First Appointment 09 Dec 2023
Oldest Company Age 43 yrs
Largest company Unimad Pharmaceuticals Pvt Ltd · ₹20.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Unimad Pharmaceuticals Pvt Ltd U24232PB1983PTC005268
Director09 Dec 20231983₹20.5 Lakh (FY 2024)Active

Board colleagues of Babar Kailay

Directorship timeline

Open interactive timeline →
Unimad Pharmaceuticals Pvt Ltd
Premium access

Shareholding and investment profile for Babar Kailay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Babar Kailay

Babar Kailay currently holds 1 directorship: Unimad Pharmaceuticals Pvt Ltd (Director, since 09 Dec 2023, revenue ₹20.5 Lakh (FY 2024)).

Babar Kailay was first appointed on 09 Dec 2023 as Director at Unimad Pharmaceuticals Pvt Ltd.

The current boards of Babar Kailay's companies include Jagjit Singh (Unimad Pharmaceuticals Pvt Ltd), Jitender Singh (Unimad Pharmaceuticals Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available